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Aneurysmal disease is the 13th leading cause of death in the 
United States, and the incidence of the disease is increasing 
annually. The etiology of abdominal aortic aneurysms (AAA) is 
presently unknown, and several theories have been advanced in 
recent years. A 'minimum' requirement for a working hypothesis is 
that it should explain two important observations: 1) There is 
increased proteolysis of the aorta (which may be due to increased 
protease activity or decreased antiprotease activity); and 2) There 
is a strong familial predisposition, with 20-30% of first-degree 
relatives of patients with AAA also affected. A male predominence 
among AAA patients has also been noted. Tissue Inhibitor of 
MetalloProteases (TIMP) is a major antiprotease of connective 
tissue and its gene has been assigned to the X chromosome. Factors 
causing relative deficiency of this inhibitor could account for 
increased proteolysis and explain genetic features of the disease. 
Previous work suggests that TIMP is deficient in AAA aorta. 
. 
Experiments were performed to determine if deficiency of 
TIMP is due to mutation resulting in decreased expression or an 
altered gene product. Northern blots of RNA from dermal fibroblast 
cultures isolated from AAA patients were probed with human TIMP 
cDNA generated by polymerase chain reaction (PCR). Human TIMP 
cDNA generated from the isolated RNA in one patient was also 
sequenced. Dermal fibroblasts expressed TIMP mRNA in all cell lines 
and there was no significant difference in TIMP expression in six 
patients vs two controls. There was a normal nucleotide sequence 
of the cDNA. 
These studies do not support the hypothesis that deficiency of 
TIMP in AAA tissue is due to a primary defect in the gene. 
Deficiency of TIMP may be due to decreased expression or binding 
under local conditions in the aneurysmal aorta or due to increased 
degradation. Further studies to rule out expression abnormalities in 
aortic smooth muscle cells and macrophages in AAA may be useful, 
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Aneurysms are described as local irreversible dilatation or 
outpouching of arterial walls with at least a 50% increase in diameter 
compared to the expected normal diameter [1,2]. They result in 
deterioration and destruction of the architecture of the arterial walls, 
resulting in loss of elastin and smooth muscle cells [3]. The 
abdominal aorta is the most common site of aneurysms in the aorta, 
and these are of two types, fusiform and saccular. Fusiform 
aneurysms are most common, and are cylindrical, involving the 
entire circumference of the aorta in the wall of the aneurysm. 
Saccular aneurysms, on the other hand, are rare and incorporate only 
a portion of the aortic wall into the wall of the aneurysm. As its 
name implies, this aneurysm is a sac-like protrusion from the aorta. 
[4]. Aneurysmal disease ranks 13th as a leading cause of death in 
the United States [5], and a recent epidemiological study reported 
that the apparent incidence of abdominal aortic aneurysms (AAA) 
has increased seven-fold between 1951 and 1980 [6]. Another study 
showed that 5% of the U.S. population over 60 years old have 
aneurysmal dilatation of the abdominal aorta, with an increase in 
incidence of new AAA of 8.7/100000 from 1950 - 60, to 
36.5/100000 from 1971-80 [7]. 
Rupture of AAA is a life-threatening occurrence. Discovered 
before rupture, successful management can lead to long term 
survival with operative motality less than 5%. However, if rupture 
occurs, the mortality increases to greater than 50%. [8,9]. Studies 
show that the 5 year risk of rupture is less than 15% in AAA up to 4 
- 
2 
cm in diameter, and increases with increasing size of AAA to more 
than 75% at 8 cm. The rate of enlargement of AAA is approximately 
0.4 cm per year. [7]. Identification of risk factors for AAA might 
permit early intervention for prevention and/or discovery of early 
asymptomatic lesions, amenable to elective repair. This would lead 
to decreased chance of rupture, and improve long term prognosis. 
Unfortunately, few factors predictive of the presence of AAA have 
been identified to date. In humans, AAA is predominantly a disease 
of elderly males [10], and population studies indicate that smoking, 
hypertension, and diet are important risk factors for development of 
these lesions [11]. However, screening a hypertensive population for 
AAA revealed aortic dilatation in only one of 245 patients [12]. It is 
known that certain strains of turkeys develop aortic aneurysms in 
males, associated with hypertension and abnormally increased levels 
of serum lipids, which are genetically determined in these species 
[13,14]. A better understanding of the etiology of AAA disease is, 
therefore, essential to more effective management of this disorder. 
The etiology of AAA has met with some controversy. Until 
recently, atherosclerosis was considered to be the major etiologic 
agent for aneurysms, accounting for about 96%, with trauma, 
syphilitic aortitis, infectious agents (bacteria, fungi, mycobacteria), 
degenerative conditions (Marfan's syndrome, Ehlers-Danlos 
syndrome, and cystic medial necrosis), collagen-vascular diseases, 
various vasculitidies, and congenital anomalies indicted in causing 
the remainder [2]. However, the atherosclerosis theory has been 
challenged because with experimental atherosclerosis, there has only 
been one aneurysm reported in dogs [15], and a single fusiform 
- 
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aortic aneurysm among 730 squirrel monkeys [16], suggesting that 
atherosclerosis does not usually induce aneurysmal disease. Other 
observations which do not support the atherosclerosis theory are the 
rarity of aneurysmal development in aortas severely involved with 
atherosclerosis, and the infrequency of distal occlusive 
atherosclerotic lesions in patients with AAA [4]. Also, it has been 
shown that there are differences in the population characteristics, 
such as age, height, weight, sex, mortality and subsequent operative 
therapy, between patients with AAA and those with atherosclerotic 
occlusive disease, suggesting that there are differences in the 
underlying pathological processes [10]. This information has led 
many investigators to propose several hypotheses to explain 
aneurysmal development. 
Proteolysis hypothesis 
The aorta is composed of elastin, arranged in the media in a 
concentric manner, a reticular network of type I and type III 
collagen fibers, and layers of smooth muscle cells. It was suggested 
that aneurysms may be secondary to a proteolytic process, since in 
aneurysmal aorta, elastin and collagen content is decreased, and 
there is increased collagenase and elastase activity, compared to 
normal aortas. [4]. Sumner et al [17] observed that the % collagen 
and % elastin in AAA is much less than in nonaneurysmal 
atherosclerotic aorta, and suggested that this is a reflection of the 
degenerative process involving the AAA wall. Collagen and elastin 
were more concentrated in the outer layer of the AAA. Many other 
investigators have defined proteolytic features of AAA disease, both 
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in serum and in tissue [18-21]. The deficit of collagen may be a 
precipitating cause of aneurysm formation and expansion. Dobrin et 
al [22] found that treatment of arteries with elastase resulted in 
dilatation, but remained intact; whereas treatment with collagenase 
resulted in rupture. 
Busuttil et al [21] found that collagenase activity was 
detectable in the AAA, but not in atherosclerotic aorta, and 
collagenase activity correlated with aneurysm size. They 
hypothesized that endogenous collagenolytic activity may be 
responsible for aneurysmal expansion and rupture, and that the 
enzyme is localized in AAA wall and inoperative in atherosclerotic 
arteries. The degree of collagen breakdown correlates with AAA 
size. This collagenase-like activity may account for the decreased 
collagen found by Sumner et al in AAA tissue, and the relative 
absence of collagenase activity in atherosclerotic aorta could explain 
the greater content of collagen observed in this tissue. Measured 
collagenase activity is greater in the inner layer than in the outer 
layer, which would support Sumner's observation of more collagen in 
the outer layer. 
Busuttil et al [23] also noted that elastase activity was 
increased in AAA, compared to atherosclerosis, while Cohen et al [19] 
demonstrated that aortic elastase was significantly higher in patients 
with AAA, compared to patients with occlusive aortic disease. These 
findings support the theory that aneurysm formation is secondary to 
a proteolytic process. Elastin content of aneurysmal aortic media is 
8.1%; normal aortic media is 35%; and atherosclerotic aortic media is 
22% [24]. The absence of collagenolytic and elastolytic activity in 
■ 
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atherosclerotic aorta not affected by aneurysmal change, points to 
the different pathogenesis between these 2 lesions [21]. 
The possibility of failure of a protease/antiprotease balance 
was suggested by Cannon and Read in 1982 [18]. Serum elastolytic 
activity and leucocyte elastolytic activity are significantly increased, 
with decreased antiproteolytic activity in AAA patients. One 
explanation of this would be that aneurysm of the aorta is associated 
with deficiency of antiprotease content. However, this condition has 
been reported only as a congenital defect by Eriksson [25], looking at 
protease and protease inhibition in chronic obstructive pulmonary 
disease (COPD). Another possibility is that even though the 
concentration and phenotype of alphaj-protease inhibitor is normal, 
its antiproteolytic capacity is not. This has been described by many 
investigators in cigarette smokers with and without emphysema [26- 
28]. Smoking is known to alter elastase/antiprotease balance in the 
lung, leading to emphysema [18,29]. Emphysema is thought to be 
secondary to proteolysis of the extracellular matrix of the lungs by 
macrophage elastases, which are inhibited by alpha1-antitrypsin in 
normal lung tissue [30-33]. 
Experiments by Cohen et al [19] support the 
protease/antiprotease imbalance theory, in that, comparing tissue 
from patients who underwent an operation on the abdominal aorta 
for ruptured AAA, an elective procedure for AAA, or aortofemoral 
bypass for occlusive disease, patients with ruptured AAA had the 
highest elastase activity, and the lowest alphaj -antitrypsin. This 
suggests that the homeostatic balance between elastase and 
- 
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antiprotease may be significantly altered in the aortic wall, especially 
at the time of aortic rupture. 
The proteolysis seen in AAA disease may not only be caused 
by an imbalance in elastase/alpha1-antitrypsin, but by other 
proteases not inhibited by alpha1-antitrypsin. Campa et al [24] 
report evidence of a metalloprotease which degrades elastin. They 
observed increased elastinolytic activity in AAA, predominantly 
secondary to a protease which hydrolyzed elastin, but is not 
inhibited by alphaj-antitrypsin or chloromethyl ketone, and has no 
immunological cross-reactivity with leucocyte elastase, which is a 
serine protease. This protease is inhibited by EDTA. Of note, there 
are only trivial amounts in atherosclerotic aorta, and none in normal 
aorta. Brown et al [20] and Reilly et al [34] have identified an 
elastolytic activity in AAA patients, with the inhibitory profile of a 
metalloelastase, which causes elastin degradation in normal aorta. 
This substance is not circulating elastase, and may originate from 
arterial aneurysmal tissue. It has affinity for aneurysm wall, is 
increased in patients with AAA, and is inhibited by copper. A 
similar metalloelastase has been isolated from macrophages in lung 
tissue [33], leading to the hypothesis that macrophages, present in 
the inflammatory infiltrate in AAA, release metalloelastases which 
are uninhibited by circulating antiproteases, resulting in the 
increased proteolytic activity observed in AAA disease [35]. Thus, 
the presence of increased proteolysis in AAA tissue is due to either 





The abdominal aortic segment below the level of the renal 
outflow is particularly prone to the formation of both true 
aneurysms and atherosclerotic occlusive disease. Special local factors 
in the abdominal segment of the aorta in certain individuals may be 
of great importance in predisposing to the development of 
aneurysmal disease. [2]. Elastin content of aortic media decreases 
down the aorta from 50% in the thoracic aorta [24] to 24% in the 
infrarenal aorta [37]. Aneurysms develop in the region of the aorta 
with decreasing elastin content [24]. Also, smooth muscle cells in the 
infrarenal aorta have decreased replication potential in culture 
compared to thoracic aortic smooth muscle cells [3]. This limited 
ability to regenerate could account for the loss of architecture of the 
infrarenal aorta, resulting in aneurysm formation. 
The aortic media is normally nourished by diffusion from the 
endothelial surface and by vasa vasorum, which penetrate into the 
media from the adventitial side. Diffusion from the lumen is 
sufficient to nourish the inner 0.5 mm of medial thickness. This zone 
contains no vasa vasorum and encompasses about 30 medial 
fibrocellular layers. Species with more than 30 medial layers have 
vasa vasorum beyond the 30th layer. The presence of medial vasa 
vasorum permits the medial layers to function at a higher level of 
medial stress, and, in large animals, the avascular inner zone 
maintains its orderly lamellar arrangement, while the outer 
vascularized zone may deviate somewhat from the usual architecture 
as the animal increases in size. Between the renal arteries and the 
aortic bifurcation, the adult human aorta is about 0.7 mm in 
' 
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thickness. For mammals, in general, this thickness would be 
expected to include an outer vascularized zone of about 10 layers. 
The human abdominal aorta has 29 layers, and is devoid of medial 
vasa vasorum. [2]. 
The infrarenal abdominal aorta is a site at which medial tensile 
stresses are relatively elevated, and where the media is 
comparatively thin. Depending upon conditions, this location may be 
vulnerable to aneurysm formation. Transmission of flowing blood 
through a junction is dependent on the junctional cross-sectional area 
ratio (ratio of the sum of the cross-sectional areas of the branch 
vessels to that of the vessel of origin). There is minimal reflection of 
the pressure pulse with a cross-sectional area ratio in the range of 
1.15 to 1.26 for a two-vessel branch. This is referred to as 'matched'. 
In most species, the infrarenal aorta to the common iliac system is 
matched with values greater than 1.15; however, humans are 
unmatched even at infancy with a value of 1.11. This value 
continues to decrease, averaging about 0.75 at age 50, contributing to 
continuous detrimental effects on the hemodynamics of the 
infrarenal aorta, and resulting in increased pulsatile reflections and 
increased lateral pressure. These effects are worsened in the 
presence of dilatation and aneurysm. 
Measurements of elasticity and deformation indicate that the distal 
portion of the infrarenal aorta is the stiffest portion of the abdominal 
aorta, and is the primary site for receiving deleterious effects from 




There is evidence to suggest that aneurysms can be inherited 
in both 'mice and men'. Mice with certain alleles for coat color at the 
X chromosome locus, Mottled, have connective tissue abnormalities, 
which result in aortic aneurysms, and decreased tensile strength of 
skin [38-40]. These abnormalities in Blotchy mouse are a result of 
impaired formation of cross-links of collagen and elastin, secondary 
to failure to generate lysine-derived aldehydes required for cross- 
linking. The mutation affects copper metabolism [41,42], and since 
copper is a cofactor for lysyl oxidase [38] (the enzyme which 
converts lysine residues to aldehydes), it is likely that this copper 
deficiency results in inactivation of the enzyme, leading to increased 
collagen and elastin solubility. This pathogenesis coincides with that 
of aneurysms produced in turkeys [43,45] and rats [46] by 
administration of lathyrogens, such as 15 -aminoproprionitrile (BAPN), 
which inactivate lysyl oxidase, resulting in decreased formation of 
lysine-derived aldehydes [2,4,43,44]. Copper deficiency has also 
been reported to produce aneurysms in poultry [47] and pigs [48]. 
In humans, there is familial tendency to AAA, suggesting a 
genetic etiology. A Swedish study reported that 18% of patients with 
AAA had at least one relative with AAA disease [49]. These findings 
were confirmed in a study of 250 patients with AAA, and 250 
controls, where 19.2% of the patients with AAA had a first-degree 
relative with AAA, compared with 2.4% of the control subjects [50]. 
Two recent screening studies show that up to 29% of brothers of 
patients with AAA also have aortic dilatation or aneuryms [51,52]. 
Tilson & Seashore [53], in a study of 50 families with AAA in two or 
■S 
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more first-order relatives, observed that the number of men with 
AAA exceeded the number of women by ratios as high as 8:1. 
Bengtsson [51] also noted a male preponderance in AAA disease with 
29% of brothers of patients with AAA also having aortic dilatation 
compared to 6% of sisters. These findings suggest an X-linked 
inheritance which would correspond to the Blotchy mouse model, 
where a known mutation on the X chromosome (affecting copper 
metabolism), predisposes to development of spontaneous aortic 
aneurysms. It is interesting that the AAA-specific elastase isolated 
by Brown [20] is inhibited by copper, and Tilson [54] documented 
decreased tissue copper levels in both experimental animals and 
patients with AAA. 
Other evidence suggestive of a genetic predisposition to AAA 
includes the observations by Tilson & Dang [55] that patients with 
AAA tend to be taller, have a greater mean body surface area, and 
have generalized arteriomegally. Also, AAA disease has been 
reported in identical twins [56]. Defects in collagen genes can 
account for some forms of aneurysmal disease [3]. A mutation in the 
gene for type III collagen in Ehlers-Danlos Type IV leads to thin skin 
and sudden rupture of large blood vessels. Also, a mutation in pro- 
alpha-2 gene for type I procollagen found in individuals with Marfan 
phenotype leads to sudden rupture of the aorta [57]. Kontusaari et 
al [58] report the development of aortic aneurysms in a family 
caused by a single base mutation in type III procollagen gene. A 
single base mutation of glycine 619 of alphaj (III) chain to a codon 
for arginine resulted in synthesis of procollagen which undergoes 
- 
thermal unfolding at a lower temperature, leading to mild bleeding 
tendencies and aortic aneurysm formation. 
Powell et al [59] have suggested that a gene on chromosome 16 
is associated with AAA. Investigation of polymorphic serum 
markers show an increased frequency of the haptoglobin alpha1 gene 
in patients with aneurysms [60]. The haptoglobin gene is located on 
the long arm of chromosome 16, close to 2 genes coding for proteins 
involved in lipid metabolism; lethicin : cholesterol acyl transferase 
(LCAT) and cholesterol ester transfer protein (CETP). CETP is 
polymorphic, and the frequency of rare polymorphisms at the CETP 
locus is increased in AAA patients. Haptoglobin functions by binding 
hemoglobin and transporting it to the liver during hemolysis. 
Haptoglobins containing the alphaj chain accelerated the degradation 
of aortic elastin by elastases in vitro by two- to four-fold, probably 
by binding to elastin. They concluded that genetic variation in 
haptoglobin and CETP genes appears to influence dilatation of the 
abdominal aorta. Also, variation at the haptoglobin locus has a direct 
effect on elastin degradation, and CETP variation could affect lipid 
metabolism and promote atherosclerosis. Thus, they suggested that a 
gene on chromosome 16 is associated with AAA, although this may 
be an as yet unidentified gene in linkage equilibrium with the 
haptoglobin and CETP genes. An autosomal pattern of inheritance for 
some AAA disease would be consistent with earlier reports by Tilson 
& Seashore [53] that 12 of 50 families with AAA had father to son 





Proteolysis, coupled with the biomechanical and physiological 
properties of the abdominal aorta, can account for AAA development, 
but do not explain the selective increase in AAA disease seen in 
relatives of patients with AAAs. The relative risk to brothers and 
sisters of patients with AAA is significantly greater than 1 indicating 
that familial factors are important in the etiology of AAA [61]. It 
appears that the etiology of AAA is related to a mechanism that links 
the proteolytic and genetic phenomena observed in AAA disease. 
Assignment of a gene coding for a Tissue Inhibitor of 
Metalloproteases (TIMP) to the X chromosome raises the possibility 
that a relative deficiency of this factor might be the link between 
proteolytic and genetic phenomena [62,63]. TIMP is a molecule of 
28.5 kDa that has been implicated as a tissue inhibitor of collagenase, 
gelatinase, proteoglycanase, and other metalloproteases [33,64,65]. 
It was localized to the X chromosome from Xp 11.1 to Xp 11.4 by in 
situ hybridization [62]. As stated earlier, there is evidence to suggest 
X-linked inheritance of AAA disease, with the number of men with 
AAA exceeding the number of women by ratios as high as 8:1 [53]. 
The presence of an inhibitor of metalloelastase on the X chromosome 
suggests that predisposition to a relative deficiency of TIMP could 
result in a protease/antiprotease imbalance, leading to proteolysis 
and AAA, predominantly in males. If this predisposition is 
detectable by restriction fragment length polymorphisms (RFLPs) in 
patients with AAA, it would be possible to screen high risk 
populations, leading to early intervention in AAA disease. Durphy et 
al [66] reported that Bglll identifies a two allele polymorphism in the 
■ 
human TIMP gene. The frequency of the 12 kb allele is .66, and the 
9.5/2.5 kb allele is .34. Recent studies by Reilly & Tilson [personal 
communication] show that the size and frequency of these alleles are 
the same in patients with AAAs. 
TIMP can be relatively deficient in tissue if it is defective, 
down-regulated, or inactivated. There are reports of low levels of 
TIMP and increased protease activity in bone cultures induced to 
undergo resorption [67], and in rabbit synovium cultures taken from 
arthritic rabbits [68]. Also, there is evidence that TIMP serves to 
regulate collagenase activity during collagen turnover in many 
connective tissues throughout the body [69]. Brophy et al [70] show 
that there is decreased TIMP in the aortas of patients with AAAs, 
measured by Western blot and radioimmunoassay. These findings 
support the TIMP hypothesis as the unifying theory between 
proteolysis and sex-limitation in AAA disease. 
The purpose of this investigation is to: 1) look at expression of 
TIMP in different cell types, 2) sequence the TIMP gene from 
patients with AAA, and 3) evaluate expression of the TIMP gene in 
patients with AAA, compared to controls. It would be useful to 
identify a genetic marker such as a mutation in the TIMP gene or a 
regulatory defect which can be used to develop simple, cost-effective 
screening tests so that individuals at high risk for AAA disease can 
be easily identified, even prior to aneurysm development. It is 
encouraging to note that the mutation reported by Kontusaari, which 




1) Edwards et al [71] reported that exposure of quiescent human 
fetal lung fibroblasts to growth factors in the presence of 
Transformation Growth Factor-G (TGF-G) resulted in inhibition of 
collagenase induction, and a synergistic increase in TIMP expression. 
Experiments were performed to examine the effect of TGF-G on TIMP 
expression in fibroblasts, smooth muscle cells, and aortic endothelial 
cells, in an effort to extrapolate Edwards' findings to cells more likely 
to be involved in aneurysm development. 
2) A relative deficiency of TIMP could be secondary to a mutation in 
the TIMP gene, resulting in a defective product, which is unable to 
inhibit elastin degradation. The TIMP gene from patients with AAA 
was sequenced and compared with the normal sequence [72]. 
3. Down-regulation of the TIMP gene could result in decreased 
transcription, resulting in decreased levels of TIMP and increased 
proteolysis. Reports that TIMP is decreased in patients with AAA 
support this hypothesis [70]. Experiments were performed to 




Materials and Methods 
TIMP expression in various cell types 
Total RNA from rat fibroblast and smooth muscle cells, and 
bovine aortic endothelial cells was obtained from Dr. Olivier Kocher 
in Dr. J. Madri's laboratory (Department of Pathology, Yale 
University). Cells were treated with transforming growth factor-13 
(TGF-B). Untreated cells were used as controls. 10 micrograms (pg ) 
of total RNA was electrophoresed in a 1.2% agarose gel containing 
formaldehyde as described in Sambrook et al [73]. The gel was made 
by melting 1.8 g agarose in 15.2 ml 5X Running Buffer (200 mM 
MOPS, 50 pM sodium acetate, pH 7.0, 10 pM EDTA, pH 8.0) and 60.8 
ml ddH20, cooling to 56°C, and adding 9.1 ml formaldehyde, 15.2 ml 
5X Running Buffer, and 52.7 ml ddH20. 7.5 pi Ethidium bromide 
(lOmg/ml) was added to a final concentration of 0.5 pg/ml. 10 pi 
loading buffer (stock solution = 250 pi formamide, 100 pi RNA-Bond 
Dye, 80 pi formaldehyde) was added to 10 pg total RNA and loaded 
with micropipetting onto the gel immersed in 2 L of IX Running 
Buffer. The gel was electrophoresed at 150 volts for 10 min, and 
then at 40 volts for 12 hours. The gel was then soaked in 10X SSC 
for 10 min, marked for orientation, photographed, and allowed to 
soak for 20 min more to wash out excess ethidium bromide. The gel 
was inverted onto a sheet of oversized Whatmann's paper, and a 
nitrocellulose filter of exact size was placed on top of the gel, with 
care taken to avoid air bubbles. This was covered by 4 sheets of 
Whatmann's paper and a 2 inch stack of paper towels cut to exact 
size. A glass plate and weight was placed on top, and RNA transfer to 
- 
the nitrocellulose filter was allowed for 5 hours, using 20X SSC as the 
transfer solution. The filter was air-dried and baked at 80°C, under 
vacuum, for 2 hours. 
Preparation of TIMP Probe for Hybridization 
The probe used for hybridization was mouse TIMP cDNA (16c8) 
kindly provided by Dr. D. Denhardt (University of Western Ontario). 
A maxiprep of the plasmid containing the 16c8 TIMP cDNA was 
performed. Cells containing the plasmid DNA were spread onto LB- 
agar plates containing Ampicillin and incubated at 37°C overnight. 
Two of the colonies were added to 2 ml LB + Amp broth and placed at 
37°C for 12 hours, with shaking (325 RPM). These 2 ml cultures 
were added to 500 ml of LB+Amp broth in a 2 L flask, and incubated 
at 37°C overnight, with shaking. 
400 ml of the culture was placed on ice for 15 min and then 
centrifuged at 5000 RPM for 15 min. The supernatant was discarded 
and the pellet was resuspended with vigorous pipetting in 16 ml of 
Solution I (3.6 ml 50% glucose solution, 2.5 ml 2 M Tris-HCl, pH 8.0, 4 
ml 0.5 M EDTA, pH 8.0, and 189 ml ddH20) and 50 mg of Lysozyme. 
This suspension was left at room temperature for 10 min and then 
mixed with 32 ml of Solution II (10 ml 20% SDS, 8 ml 5 M sodium 
chloride, and 182 ml ddH20), and placed in an ice-H20 bath for 5 min. 
16 ml of pre-cooled Solution III (60 ml potassium acetate, 11.5 ml 
glacial acetic acid, and 128.5 ml ddH20) was added and placed in ice- 
H20 bath for 5 min. The mixture was spun at 5000 RPM for 15 min. 
The supernatant was filtered through gauze and spun again at 5000 
RPM for 15 min. 0.6 volumes of isopropanol was added and left at 
- 
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-20°C for 15 min. The solution was spun at 6000 RPM for 15 min at 
0°C, drained well, and the pellet was resuspended in 10 ml TE buffer 
(10 mM Tris-HCl, pH 8.0, 1 rnM EDTA, pH 8.0) with Tris-HCl, pH 8.0 
added until the pH of the solution was greater than 6.5. 
10 g of Cesium chloride was added to the suspension and it was 
transferred to a 30 ml ultracentrifuge tube, which was topped-up 
with a CsCl:TE solution (1:1 w/v) and 0.5 ml ethidium bromide (10 
mg/ml). This mixture was spun at 48000 RPM for 12 hours at 15°C. 
The DNA band was extracted with a 18-gauge needle and transferred 
to a 5 ml ultracentrifuge tube. Ethidium bromide was added and this 
solution was spun at 55000 RPM for 12 hours at 15°C. 
The DNA band was extracted as before and transferred to a 15 
ml Falcon tube. Ethidium bromide was removed by extracting with 
one volume of 90% butanol, vortexing, and discarding the top phase. 
This was repeated six times until the DNA solution was clear. The 
solution was placed in a dialysis bag and submerged in 2 L TE with 
stirring for 30 min. This was repeated twice and the OD260/28Q was 
checked. 
Labeling of TIMP cDNA Probe for Hybridization 
5 pg of plasmid DNA containing the mouse TIMP cDNA (16c8) 
was linearized by digestion with PvuII at 37°C for 1 hour. PvuII cuts 
in the polylinker of the plasmid DNA. 10 pi of the digest was 
electrophoresed on a 1.5% agarose minigel to evaluate efficiency of 
digestion. DNA was radiolabeled by modification of the method of 
oligolabeling described by Feinberg & Vogelstein [74]. 60 ng of 
linearized plasmid DNA containing the mouse TIMP cDNA was added 
' 
to 32.5 pi ddH20 and placed at 95°C for 5 min, 37°C for 5 min, and 
then on ice. This solution was incubated with 10 pi Oligolabeling 
Buffer (-dCTP) [74], 2 pi bovine serum albumin (10 mg/ml), 5 pi 32P- 
dCTP, and 2 U Klenow DNA polymerase I, at room temperature 
overnight. The reaction was stopped with 50 pi STE buffer and 
purified through a Sephadex G-50 spun column [73]. The column 
was prepared by plugging the tip of a 1 cc syringe with glass wool, 
filling with Sephadex G-50 solution, and spinning in a 15 ml Falcon 
tube until the G-50 column was compact. The column was washed 
twice with 200 pi of STE, with spinning. The labeling reaction 
mixture was extracted with phenolrchloroform, and the aqueous 
phase was run through the column. The sample was recovered (~100 
pi), checked with a Geiger counter, and used for hybridization. 
Prehvbridization and Hybridization 
The baked filter was wetted in 2X SSC and placed into a 
hybridization slot containing 15 ml of prehybridization solution (3.75 
ml 20X SSC, 7.5 ml formamide, 3.0 ml 50X Denhardt's Solution, 0.5 ml 
sodium phosphate, 0.5 ml 20% SDS, and 250 pi salmon sperm DNA 
boiled for 10 min) at 42°C for 2 hours. The prehybridization solution 
was poured off, and 15 ml of hybridization solution (3.75 ml 20X SSC, 
7.5 ml formamide, 0.5 ml 50X Denhardt's Solution, 0.2 ml sodium 
phosphate, 0.5 ml 20% SDS, 3.0 ml Dextran sulfate, and 250 pi salmon 
sperm DNA and 100 pi labeled TIMP cDNA boiled for 10 min) was 
added, and left at 42°C for 20 hours. The filter was transferred into 
2X SSC to remove extremely loose counts, and washed as follows: 
twice in 1 L 2X SSC/0.1% SDS at 42°C for 20 min each, and three 
. 
times in 0.6X SSC/0.1% SDS at 42°C for 30 min each. The filter was 
placed onto Whatmann's paper, air-dried, covered with Saran wrap, 
and exposed to Kodak autoradiography film at -70°C for 48 hours. 
The film was developed and the blots of TIMP hybridization were 
scanned to determine the density of TIMP expression using a density 
scanner in Dr. S. Altman's laboratory (Department of Biology, Yale 
University). 
RNA isolation from human fibroblasts 
Fibroblast cultures were established from abdominal skin 
obtained during the incision for aortic reconstruction in six patients 
with aneurysm disease, and one control patient with occlusive 
disease. The skin specimens were washed in phosphate buffered 
saline (PBS), 70% isopropanol, and again in PBS, then defatted, 
minced, placed dermal side down on petri-dishes, and allowed to 
dessicate for 45 minutes. Dulbecco's modified eagles medium 
supplanted with 10% fetal bovine serum (Gibco, Grand Island, NY) 
and 10,000 U/ml penicillin/streptomycin (Gibco) was then added. 
The cells were allowed to reach confluence (approximately one 
month), passaged with 0.25% trypsin, and plated onto 150 cm3 
dishes. When confluent, the cells were washed with 10 ml PBS X 2 
and 3.5 ml 4 M GIT solution (guanidium isothiocyanate (Boehringer), 
20 mM sodium acetate pH 5.2, 0.5% N-lauryl sarcosine, B- 
mercaptoethanol) was added. The viscous solution was then drawn 
up via a 21-guage needle into a 10 cc syringe and drawn up and 
down 4 times. The GIT solution/cell lysate was layered onto 1.5 ml 
of 5.7 M CsCl in ultracentrifuge tubes, and centrifuged in a Beckman 
■ 
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L8-70M at 35000 RPM for 18 hours at 18°C. The supernatant was 
aspirated and the pellet was resuspended in 200 pi TES (10 mM Tris 
pH7.4, 5 mM EDTA, 1% SDS). A chloroform/butanol (4:1) extraction 
was performed X 2. 40 pi 3 M sodium acetate and 1 ml 95% EtOH 
were added to the final 360 pi RNA/TES. This was placed at -80°C 
for 2 hours, and then centrifuged at 14000 RPM for 30 minutes at 
4°C. 360 pi of water was added and 10 pi of this solution, plus 490 pi 
water was added to determine OD260/28(r 40 pi of 3 M sodium 
acetate and 1 ml 95% EtOH were added, and the RNA was stored at 
-80°C as a suspension. 
Sequencing of TIMP gene in AAA 
Total fibroblast RNA isolated from AAA patient #2 (figure 3,4) 
was prepared as above. Complementary DNA (cDNA) was 
transcribed from 2 pg of total RNA in a 50 pi reaction containing 50 
mM Tris-HCl, pH 8.3, 75 mM KC1, 10 mM dithiothreitol, 3 mM MgCl2, 
500 mM each of all four deoxynucleotides, 2.5 pg random hexamers 
(pdN6), 1 U placental ribonuclease inhibitor and 800 U recombinant 
Moloney murine leukemia virus reverse transcriptase (Bethesda 
Research Labs, Gaithersburg, MD). Incubation was at 37°C for 1 hour. 
Polymerase Chain Reactions fPCR) 
Oligonucleotide primers were synthesized by Dr. T. Barnett 
(Molecular Diagnostics, Inc., West Haven, CT). PCR for TIMP cDNA- 
specific amplification was performed by incubating 5 pi of cDNA in a 
100 pi reaction mix with 10 mM Tris-HCl, pH 8.3, 50 mM KC1, 1.5 mM 
MgCl2, 0.001% gelatin, 200 pM each dNTP, 1 pM each TIMP 
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oligonucleotide primer, and 25 U/ml AmpliTaq DNA polymerase 
(Perkin Elmer/Cetus, Norwalk, CT). Primer pairs used for 
amplification were 5' forward oligo TIMP1 
(5'AGATCTAGCGCCCAGAGAGACACCAGAGA3'), 3' reverse oligo TIMP2 
(5'GGGATCCGGGTGGACACTGTGCAGGCTTC3'), and internal forward 
oligo TIMP3 (5’GGGATCCAAGCCTTAGGGGATGCCGCTGA3'); restriction 
endonuclease cleavage sites for Bglll (AGATCT) or BamHI (GGATCC) 
are incorporated at the 5' ends of the appropriate oligonucleotide. 
Amplification in a Perkin/Elmer thermocycler was for a total of 40 
cycles as follows: cycle 1 (94°C, 5 min; 55°C, 2 min; and 72°C, 3 min), 
cycles 2 through 39 (94°C, 1 min; 55°C, 2 min; and 72°C, 3 min) and 
cycle 40 (94°C, 1 min; 55°C, 2 min; and 72°C, 8 min). Products of PCR 
reaction were analyzed by electrophoresis of 5 pi on 1.5% 
agarose/1.5% NuSieve agarose gels. 
Cloning and Sequencing of PCR Products 
PCR reactions prepared by priming of cDNA with oligos TIMP1 
and TIMP3, or with TIMP2 and TIMP3, were extracted by 
phenol/chloroform, ethanol precipitated and resuspended for 
digestion with restriction endonucleases BamHI and Bgill (TIMP1/3 
product) or Bglll alone (TIMP2/3 product), then electrophoresed on 
1% LGT (low gelling temperature)-agarose. Ethidium bromide 
staining bands corresponding to TIMP1/TIMP3 products (-700 bp) 
and TIMP2/TIMP3 products (-450 bp) were excised, melted with 0.3 
M sodium acetate and 0.1 M Tris-HCl, mixed with water-saturated 
phenol and cooled on ice. Separation of agarose and phenol layers 
from aqueous was by centrifugation. DNA in the upper layer was 
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precipitated by addition of two volumes of ethanol and frozen in 
dry-ice. Pelleted DNA was resuspended in 5 pi H20. DNA segments 
were then prepared for sequencing by ligation with BamHI-cleaved 
Bluescript KS+ plasmid vector DNA (Stratagene, San Diego, CA). 
Reactions were 100 ng of cleaved DNA, 2 ng BamHI-cleaved vector 
DNA, 10 mM Tris-HCl, pH 7.5, 10 mM DTT, 10 mM MgC12, 2 mM ATP, 
and 400 U T4 DNA ligase (New England Biolabs, Beverly, MA) in 15 pi 
at 15°C overnight. Transformation of ligated DNA was into 
competent E. coli DH5-alpha cells spread onto LB-agar plates 
containing 75 pi of 2% X-gal and 15 pi of 100 mM IPTG 
(isopropylthiogalactoside). Potential recombinant candidates were 
picked from among the white colonies on the plates and grown in 2 
ml LB broth at 37°C overnight. 
Minipreps of plasmid DNA were performed. 1.4 ml of 2 ml 
cultures was pipetted into eppendorf tubes and spun for 2 min. The 
supernatant was discarded and the pellet resuspended in 300 pi 
STET buffer (8% sucrose, 5% Triton X100, 50 mM Tris-HCl, pH 8.0, 50 
mM EDTA). 25 pi Lysozyme (10 mg/ml) was added to each tube 
which were vortexed for 2 min, boiled for 1 min, and spun for 15 
min. 200 pi of supernatant was mixed with 230 pi isopropanol, 
placed at -20°C for 30 min, and spun for 5 min. The pellets were 
resuspended in 50 pi TE buffer (10 mM Tris-HCl, 8.0, 1 mM EDTA), 
extracted with phenol X2, CHC13 XI, and precipitated with 0.3 M 
sodium acetate, pH 7.0, and two volumes of ethanol in a dry-ice bath. 
Tubes were spun for 10 min and the DNA pellets were washed with 
70% ethanol in a speed-vac. 50 pi TE and 1 pi RNAse (10 mg/ml) 
were added to each tube, followed by incubation at 70°C, 10 min, and 
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37°C, 15 min. Recombinant clones were determined by digestion of 
plasmid DNA at flanking sites with EcoRI/Xbal, since Bglll termini 
cannot be excised after ligation to complementary BamHI ends. 
Plasmid DNAs demonstrating inserts of the expected sizes (either 
-700 or 400 bp) were sequenced in both directions directly from 
double-stranded DNA by the dideoxynucleotide method of Sanger et 
al, described in [73]. The primers employed for sequencing directly 
from Bluescript DNA were T7 and T3 in the presence of 35S-dATP 
(Amersham Corp.). Sequence analysis was performed using the 
University of Wisconsin Genetics Computer Group programs. 
TIMP expression in AAA 
Total fibroblast RNA from six AAA patients and one patient 
with occlusive disease was prepared as described above. 15 pg 
aliquots of total RNA from each cell line was electrophoresed in a 
1.2% agarose gel containing formaldehyde as described above. 15 pg 
of total RNA from a lymphoblast cell line which does not express the 
TIMP gene was obtained from Dr. Stefano Martinotti in Dr. A. 
Hayday's laboratory (Department of Biology, Yale University) and 
used as a negative control (figure 3A,3B, #8). A second gel was run 
with 10 pg aliquots of total RNA from AAA patients (#1, 2, 6, and 7), 
the patient with occlusive disease (#5), and total RNA from a normal 
human fibroblast cell line donated by Dr. P. Seperack (Miles 
Pharmaceuticals, West Haven) which was used as a second positive 
control (figure 4A,4B, #9). RNA was transferred to nitrocellulose 
filters, and prehybridized and hybridized at 42°C in prehybridization 
and hybridization solutions as previously described. Blots were 
■' 
washed to a stringency of 0.1X SSC/0.1% SDS at 42°C, air-dried, and 
autoradiographed at -70°C for 36 hours. 
The probe used for hybridization was human TIMP cDNA, 
generated from total fibroblast RNA from AAA patient #2, and 
amplified via PCR, as described earlier. Bluescript plasmid containing 
the PCR product from oligos TIMP 2/TIMP3 was linearized by 
digestion with BamHI at 37°C for 1.5 hours. 60 ng of linearized DNA 
was radiolabeled and purified as previously described. 
■ ' ■ 
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Results 
Total RNA from rat fibroblasts and smooth muscle cells, and 
bovine aortic endothelial cells was probed with mouse TIMP cDNA to 
detect TIMP expression in different cell types. The TIMP gene is 
expressed in fibroblasts, smooth muscle cells, and aortic endothelial 
cells (figure 1A). TIMP expression is increased two- to three-fold in 
cells exposed to TGF-B (figure IB). 
Human TIMP cDNA was generated from total RNA isolated from 
dermal fibroblast cell lines of patients with AAA. TIMP cDNA was 
amplified via PCR, cloned into Bluescript KS+ plasmid vector DNA, and 
sequenced in both directions directly from dsDNA by the chain- 
termination dideoxynucleotide method of Sanger et al. The sequence 
of the TIMP cDNA derived from cell line #2 (figure 3,4) was identical 
in nucleotide, and expected amino acid sequence (figure 2B) to that 
published by Docherty et al [72]. 
Dermal fibroblasts cultures were established from patients 
with AAA and a positive family history for AAA. Five of the six 
patients were male, and ages ranged from 67 years to 77 years. The 
only surviving control cell line (figure 3,4, #5) was established from 
an age-matched female patient who underwent abdominal surgery 
for occlusive disease. Total RNA from a normal human fibroblast cell 
line was donated by Dr. P. Seperack (Miles Pharmaceuticals, West 
Haven) and used as a second positive control (figure 4A,4B, #9). 
RNA was probed with human TIMP cDNA to compare TIMP 
expression in AAA vs. controls. Densitometry studies were 
performed in Dr. S. Altman's laboratory (Department of Biology, Yale 
. 
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University). TIMP is expressed in the fibroblast cell lines, but not in 
equivalent amounts of the lymphoblast cell line (figure 3A,3B). 
There is no significant difference in TIMP expression in patients with 




The results in figure 1 are consistent with the findings of 
Edwards et al that TIMP is expressed in fibroblasts, and there is 
increased expression in the presence of TGF-B. The result most 
relevant to this paper is that TIMP is present in smooth muscle cells 
and aortic endothelial cells and can be regulated by growth factors. 
In order to implicate TIMP in AAA development, it must be present 
in the cells most directly affected by AAA formation, and have the 
ability to be regulated. These results show that both these criteria 
are met. 
Figure 1A shows an abundance of nonspecific binding of the 
probe resulting in the bands in the region of TIMP mRNA being less 
discernable. Since the nonspecific binding is confined to the lanes of 
transferred RNA, it is most likely secondary to complementary 
sequences in the plasmid DNA used to clone the mouse TIMP cDNA 
16c8. The plasmid was only linearized prior to labeling. The 
decreased intensity of the signals in the region of TIMP expression 
could also be due to the level of stringency used while washing the 
filter. The TIMP gene has approximately 70% conserved sequences 
across species, therefore, a higher level of hybridization would be 
expected than was observed. It is possible that the high 
concentration of the cloning plasmid DNA resulted in decreased TIMP 
specific labeling. The TIMP cDNA was ~600 bp, whereas the plasmid 
DNA was almost 2000 bp. It would have been better to cut the TIMP 
sequences out of the plasmid to allow a higher concentration of 
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labeled TIMP DNA, resulting in more specific hybridization, and a 
cleaner northern blot. 
Figure 2B shows that the sequence of TIMP cDNA from one 
AAA patient is identical to the normal sequence previously 
published. It would be useful to look at the sequence of some of the 
other TIMP cDNAs to confirm that there is no sequence change in any 
of the cultured AAA cell lines. Using PCR to amplify the TIMP cDNA 
has potential for error since early misincorporation of one or more 
bases could be retained and propagated through succeeding cycles of 
amplification, resulting in an increased frequency of error products. 
The use of Taq DNA Polymerase reduces the possibility of errors 
since Taq DNA Polymerase has high fidelity, with a misincorporation 
rate/cycle of 2 x 10'4, and only highly complementary substrate 
remains as the reaction approaches the temperature at which 
catalysis occurs [75]. PCR based on Taq DNA Polymerase represents a 
form of "cell-free molecular cloning" that can accomplish 
amplification in 3-4 hours which might take days or weeks of 
biological growth and biochemical purification [75]. 
Figures 3 and 4 show no significant difference in TIMP 
expression in dermal fibroblasts from AAA patients compared to 
patients without AAA. Evidence of decreased TIMP expression in 
AAA would support the hypothesis that decreased TIMP expression 
accounts for the observed TIMP protein deficiency in aneurysmal 
aorta tissue. However, the higher level of TIMP expression seen in 
the control (figure 3B, #5) is not significant since the amount of 
variation is within the accepted range. Also, when the filter was 
probed with a human tubulin gene PCR product (395 bp) to evaluate 
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the efficiency of the hybridization technique, the intensities of the 
blots showed comparable variation as seen when probed with TIMP. 
Thus, the difference observed by densitometry sudies in figure 3B is 
not significantly real, and may be a result of better loading of the gel 
or better transfer of RNA to the nitrocellulose filter in the case of #5. 
Evidence of similar TIMP expression in AAA and nonAAA patients is 
confirmed in figure 4B. Unfortunately, these results are based on 
only two controls, and it is not possible to state undoubtedly that 
AAA patients do not have down-regulation of TIMP expression. It 
would be helpful to have more normal and nonAAA controls to 
confirm these results. 
The deficiency of TIMP gene product in AAA which has been 
observed [70], may be secondary to loss of elastin, since TIMP is a 
matrix-associated protein [76], and there is decreased matrix protein 
in AAA [17,24,37]. Another possibility is that TIMP deficiency is 
site-specific, and localized to the infrarenal aorta. Further studies 
with aortic smooth muscle cells and in situ hybridization using 
abdominal aortic tissue would help to evaluate these possibilities. 
Dermal fibroblasts were used in this study because most of the work 
on TIMP expression has been done using dermal fibroblasts, and it 
would have been useful to detect a systemic defect in AAA disease, 
which would facilitate the development of a simple, cost-effective 
screening technique. Also, abdominal aortic smooth muscle cells 
have decreased replication potential [3] and it is difficult to 
determine whether findings are primary, or merely secondary 




Aneurysmal disease is the 13th leading cause of death in the 
United States and the incidence of the disease is increasing annually 
[5-7]. Rupture of AAA is a life-threatening occurrence with 
mortality up to 80% [61]. Several hypotheses have been proposed to 
explain AAA development including proteolysis, 
biomechanical/physiologic phenomena, and genetic predisposition. 
There is a considerable amount of convincing evidence in support of 
proteolytic and genetic phenomena. It would be useful to discover a 
unifying entity between these two hypotheses. Assignment of TIMP 
to the X chromosome raises the possibility that a relative deficiency 
of this inhibitor of metalloproteases may be the link between the 
increased protease activity and the male preponderance observed in 
AAA disease. Studies describing decreased antiprotease inhibitory 
activity [18,19] and decreased TIMP in AAA tissue [70] support this 
hypothesis. It was felt that the apparent low incidence of AAA in 
women may be due to a gene dosage effect, where the TIMP gene 
escapes inactivation on either X chromosome [36]. Genes have been 
sudied at the region on the short arm of the X chromosome where 
TIMP has been localized which escape inactivation, and are 
expressed from both X chromosomes [77]. Recent work has shown 
that there is a 100-fold less transcription of the TIMP gene from the 
inactive X chromosome than from the active X suggesting that the 
TIMP gene is inactivated on one X chromosome in females, thus 
ruling out the gene dosage hypothesis [78]. 

TIMP is expressed in various cell types (figure 1) including 
fibroblasts, smooth muscle and aortic endothelial cells. TIMP is also 
present in skin and corneal fibroblasts, uterine smooth muscle cells, 
ovaries, fetal osteoblasts, tendon and cartilage explants, aortic 
smooth muscle cells, serum and amniotic fluid [69]. This ubiquitous 
nature of TIMP has implicated it as a major factor in the regulation 
of connective tissue turnover throughout the body [69]. 
The presence of a primary defect in the TIMP gene could result 
in a defective gene product with decreased inhibitory function, or in 
down-regulation of the gene leading to decreased expression and a 
deficiency of the inhibitor in tissue. Detection of such a defect could 
be useful to a better understanding of the disease process and 
development of a screening test to identify high risk populations, 
thus allowing earlier intervention for prevention or elective repair of 
AAA. The present studies do not support the hypothesis that the 
deficiency of TIMP in aneurysmal aorta is due to a primary defect in 
the gene, since there is no apparent sequence change, and no 
significant difference in TIMP transcription in dermal fibroblasts. 
The deficiency of TIMP gene product in AAA [70] may be secondary 
to loss of elastin, since TIMP is a matrix-associated protein [76], and 
there is decreased matrix protein in AAA [17,24,37]. Another 
possibility is that TIMP deficiency is site-specific, and localized to the 
infrarenal aorta. Abdominal aortic smooth muscle cells have 
decreased replication potential [3] and the effect of factors which 
inhibit or degrade TIMP would be potentiated since there is 
decreased turnover of cells. Further studies with aortic smooth 
muscle cells and in situ hybridization using abdominal aortic tissue 
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may be helpful, although it will be difficult to determine whether 
findings are primary, or merely secondary features of AAA. 
The decrease in TIMP in AAA tissue may be due to an increase 
in neutrophil elastase activity [70]. TIMP can be degraded by 
neutrophil elastase and other serine proteases [80], and Cannon [18] 
and Cohen [79] have shown that neutrophil elastase activity is 
increased and antiproteolytic activity decreasd in AAA. Thus, 
neutrophil elastase may potentiate metalloprotease activity by 
inactivation of its inhibitor. It is possible that aneurysm patients 
produce normal concentrations of TIMP that is less biologically 
active, i.e., TIMP that is less able to associate with the matrix, less 
able to interact with its binding-site, or more susceptible to 
degradation. This phenomena has been reported in cigarette 
smokers with and without emphysema, where a normal 
concentration and phenotype of alphaj-antiprotease is present, but 
antiproteolytic capacity is not [26-28]. Thus, the level of TIMP 
expression may be normal, but post-transcriptional or translational 
factors may affect TIMP maturity, stability, and/or availability. 
TIMP is more soluble in AAA tissue, therefore, the deficiency of 
TIMP may be due to increased degradation. TIMP is stable at 
extremes of temperature and pH [81]. It is possible that factors 
leading to decreased heat stability of TIMP in aneurysm patients 
could result in inactivation, and loss of its inhibitory action. 
Kontusaari [58] showed that a mutation leading to synthesis of a less 
heat stable procollagen resulted in aneurysm formation in a family. 
Mature TIMP has several N-linked glycosylation sites which are 
important for function [82]. Deficient or defective glycosylation in 

aneurysm patients could result in decreased inhibition of 
metalloproteases. Further studies of the TIMP gene product from 
patients with AAA may be useful in resolving these issues. 
The etiology of AAA is most likely multifactorial with the 
increased propensity for AAA in the infrarenal aorta due to 
biomechanical/physiological factors. Some aortic aneurysms are due 
to defects in structural proteins whether as a result of mutations in 
the structural genes themselves [58], or in the pathway leading to 
formation and turnover of structural proteins, as in the Blotchy 
mutation [38-42]. Elastase specific to AAA tissue is inhibited by 
copper, and may have increased activity in states of copper 
deficiency, which may be genetically controlled. Specific gene 
markers on chromosome 16 are associated with AAA [59]. Certain 
haptoglobin phenotypes have been found to accelerate elastolysis by 
two- to four-fold in vitro. It is possible that haptoglobin makes 
elastin more susceptible to degradation by binding to it, or there may 
be a gene on chromosome 16 that is associated with AAA, and in 
linkage equilibrium with the haptoglobin gene. These findings can 
explain proteolysis and the familial tendency for AAA, but does not 
account for the apparent male preponderance among patients with 
AAA, therefore, this may only account for some AAA. 
The genetic basis of AAA formation is still to be determined. It 
is hoped that ultimately a specific gene abnormality or abnormalities 
will be identified to permit earlier detection of individuals 
predisposed to AAA formation, even prior to AAA development. 
Screening tests could then be developed to 1. detect previously 
unknown AAA for resection or observation, 2. permit more accurate 
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identification of affected and unaffected individuals in pedigrees to 
allow a more precise definition of mode of inheritance of 
susceptibility to AAA formation so that linkage studies to identify 
specific genes involved may be undertaken, and 3. identify a large 
enough pool of patients with small AAAs so that the natural history 
of AAA development can be studied. This would allow investigators 
to determine factors which contribute to enlargement, and permit 
randomized trials of drug therapy to retard or prevent AAA growth. 
The genetic predisposition for AAA development is 
exacerbated by environmental risk factors such as hypertension, 
smoking, and diet. Patients with AAA should have their 
hypertension controlled, and should be encouraged not to smoke. 15 - 
adrenergic blockade has been shown to delay the formation of aortic 
aneurysms in Blotchy mouse [83] and humans [84], and to decrease 
the chance of rupture in turkeys with aneurysmal disease [13,14,45], 
Propanolol inhibits development of aneurysms by a direct effect on 
collagen cross-linking independent of its effects on heart rate and 
blood pressure [45]. Therefore, treatment with 15-blockers may have 
a two-fold effect: contolling hypertension and slowing aneurysm 
formation. Calcium-channel blockade has also been suggested to 
slow the progression of the disease in patients with small AAA [85]. 
Patients with AAA disease and their first-degree relatives should be 
screened by abdominal ultrasound, at least annually, to monitor 
aortic dilatation. Aneurysm size greater than 5 cm correlates with a 
clinically significant risk of rupture, therefore, elective repair should 
be considered if there is rapid expansion or increase in size to 5 cm 
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Figure 1 A. TIMP Expression in Different Cell Types 
1 0 ng of total RNA from rat fibroblasts (1,2), rat smooth muscle 
cells (3,4), and bovine aortic endothelial cells (5,6) were 
electrophoresed in an agarose gel containing formaldehyde, 
transferred to a nitrocellulose filter, and probed with mouse TIMP 
cDNA. Northern blot shows TIMP expression in different cell types, 



















Figure 1 B. TIMP Expression in Different Cell Types 
Densitometry was performed on the northern blot shown in 
figure 1 A to evaluate the effect of TGF-p on TIMP expression in 
rat fibroblasts (1,2), rat smooth muscle cells (3,4), and bovine 
aortic endothelial cells (5,6). 




1 agcgcccagagagacaccagagadcccaccatggccccctttgagcccctggcttctggc 60 
MAPFEPLASO 
61 atcctgttgttgctgtggctgatagcccccagcagggcctgcacctgtgtcccaccccac 120 
XLLLLWLIAP8RACTCVPPH 
121 ccacagacggccttctgcaattccgacctcgtcatcagggccaagttcgtggggacacca 180 
PQTAFCNSDLVXRAKFVGTP 
181 gaagtcaaccagaccaccttataccagcgttatgagatcaagatgaccaagatgtataaa 240 
EVNQTTLYQRYBI KMTRMYR 
TIMP* 
241 gggttccaagccttaggggatgccgctgacatccggttcgtctacacccccgccatggag 300 
gfqalgdaadxrfvytpamb 
301 agtgtctgcggatacttccacaggtcccacaaccgcagcgaggagtttctcattgctgga 360 
svcgyfhrshnrsbefliag 
361 aaactgcaggatggactcttgcacatcactacctgcagtttcgtggctccctggaacagc 420 
XLQDGLLHITTCSFVAPWNS 
421 ctgagcttagctcagcgccggggcttcaccaagacctacactgttggctgtgaggaatgc 480 
lslaqrrgftktytvgceec 
481 acagtgtttccctgtttatccatcccctgcaaactgcagagtggcactcattgcttgtgg 540 
TVFPCLS1PCKLQSGTHCLW 
541 acggaccagctcctccaaggctctgaaaagggcttccagtcocgtcaccttgcetgcctg 600 
tdqilqgsbkgfqsrhlacl 
601 cctcgggagccagggctgtgcacctggcagtccctgcggtcccagatagcctgaatcctg 660 
PREPGLCTWQSLRSQ1A 
661 cccggagtggaagctgaagcctgcacagtgtccaccc 697 
TIMP2 
Figure 2A. Oligonucleotide Primer Locations for PCR 
TIMP1 (5' agatctagcgcccagagagacaccagaga 3'), TIMP2 
(5' g&gatccgggtggacactgtgcaggcttc 3'), TIMP3 
(5' gggatccaagccttaggggatgccgctga 3'); Bglll (AGATCT) and BamHI 
(GGATCC) cleavage sites were incorporated at the 5' ends of the 
oligos. TIMP cDNA generated from human total fibroblast RNA from 
a patient with AAA (figure 3, 4, #2) was mixed with pairs of these 
primers for TIMP cDNA specific amplification. 
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1 agcgcccagagagacaccagagadcccaccatggccccctttgagcccctggcttctggc 50 
NAPFEPLA80 
61 atcctgttgttgctgtggctgatagcccccagcagggcctgcacctgtgtcccaccccac 120 
ILLLLKLIAP8PACTCVPPH 
121 ccacagacggccttctgcaattccgacctcgtcatcagggccaagttcgtggggacacca 180 
PQTAPCNSDLVI .RAKfVOTP 
181 gaagtcaaccagaccaccttataccagcgttatgagatcaagatgaccaagatgtataaa 240 
EVNQTTIYQRYBI KMTKMYK 
241 gggttccaagccttaggggatgccgctgacatccggttcgtctacacccccgccatggag 300 
GFQALGDAADXRrVYTPAMB 
301 agtgtctgcggatacttccacaggtcccacaaccgcagcgaggagtttctcattgctgga 360 
svcgyfhrshnrseefliag 
361 aaactgcaggatggactcttgcacatcactacctgcagtttcgtggctccctggaacagc 420 
KLQDGLLHX TTCS FVAPWN5 
421 ctgagcttagotcagcgccggggcttcaccaagacctacactgttggctgtgaggaatgc 480 
lslaqrrgftktytvgcbec 
481 acagtgtttccctgtttatccatcccctgcaaactgcagagtggcactcattgcttgtgg 540 
TVFPCLSIPCKLQSGTHCLW 
541 acggaccagctcctccaaggctctgaaaagggcttccagtccogtcaccttgcctgcctg 600 
tdqllqgsekgfqsrhlacl 
601 cctcgggagccagggctgtgcacctggcagtccctgcggtcccagatagcctgaatcctg 660 
PREPGLCTWQSLRSQIA 
661 cccggagtggaagctgaagcctgcacagtgtccaccc 697 
Figure 2B. Sequence of TIMP cDNA from AAA Patient 
PCR products from TIMP cDNA primed with oligos TIMP1 & TIMP3, 
or with TIMP2 & TIMP3 were ligated with BamHI-cleaved Bluescript 
KS+ plasmid vector DNA. Sequencing was performed in both 
directions directly from double-stranded DNA by the 
dideoxynucleotide method of Sanger et al. The sequence is identical 
in nucleotide and amino acid sequence to that published by Docherty 
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Figure 3A. TIMP Expression in AAA 
15 Mg of total dermal fibroblast RNA from six patients 
with AAA (1,2,3,4,6,7) and one patient with occlucive 
disease (5), and 15 pg of total lymphoblast RNA (8), were 
electrophoresed, transferred to a nitrocellulose filter, 
and probed with human TIMP cDNA. Northern blot shows 
TIMP expression in AAA and nonAAA dermal fibroblasts. 
TIMP is not expressed in the lymphoblast cell line. (TIMP 




Figure 3B. TIMP Expression in AAA 
Densitometry was performed on the northern 
blot shown in figure 3A, to compare TIMP expression in 
AAA patients (1,2,3,4,6,7) with a nonAAA control (5). Cell 
line ^8 is a non-TIMP expressing control. 
(U = arbitrary densitometry units) 
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Figure 4A. TIMP Expression in AAA 
10 ng of total dermal fibroblast RNA from four patients 
with AAA (1,2,6,7), one patient with occlusive disease (5), 
and one normal patient (9) were electrophoresed, 
transferred to a nitrocellulose filter, and probed with 
human TIMP cDNA. Northern blot shows TIMP expression 








Figure 4B. TIMP Expression in AAA 
Densitometry was performed on the northern blot shown 
in figure 4A, to compare TIMP expression in AAA 
patients (1,2,6,7), with two nonAAA controls: a patient 
with occlusive disease (5), and a normal patient (9). 
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